Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Operating Leases (2019 - 2025)

Historic Operating Leases for CollPlant Biotechnologies (CLGN) over the last 7 years, with Q3 2025 value amounting to $2.2 million.

  • CollPlant Biotechnologies' Operating Leases fell 1234.22% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 1234.22%. This contributed to the annual value of $2.3 million for FY2024, which is 1025.64% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Operating Leases of $2.2 million as of Q3 2025, which was down 1234.22% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' Operating Leases registered a high of $3.1 million during Q4 2021, and its lowest value of $2.1 million during Q1 2025.
  • In the last 5 years, CollPlant Biotechnologies' Operating Leases had a median value of $2.5 million in 2023 and averaged $2.5 million.
  • The largest annual percentage gain for CollPlant Biotechnologies' Operating Leases in the last 5 years was 1177.15% (2022), contrasted with its biggest fall of 2288.77% (2022).
  • Quarter analysis of 5 years shows CollPlant Biotechnologies' Operating Leases stood at $3.1 million in 2021, then fell by 22.89% to $2.4 million in 2022, then grew by 6.42% to $2.5 million in 2023, then fell by 10.26% to $2.3 million in 2024, then dropped by 5.41% to $2.2 million in 2025.
  • Its Operating Leases was $2.2 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.1 million in Q1 2025.